Research shows Depo-Provera users were 5.6 times more likely to develop these brain tumors compared to women who did not receive the injections.
The aforementioned study confirms a direct link between Depo-Provera and brain tumor development.
Here's what the researchers found:
Pfizer, which manufactures Depo-Provera, finally addressed these issues last April 2024. They admitted the problem and said they're working with health agencies to update their warning labels. This is a notable change; they're finally recognizing what the medication can do to women's health in the long term.
Your personal risk of getting a brain tumor from Depo-Provera depends on several factors:
Our team has spent over 35 years handling pharmaceutical injury cases. We know exactly what medical evidence links Depo-Provera to meningiomas. Show us your medical records - both your shot history and your tumor diagnosis - and we'll evaluate your case.
Call us today for a free case review, and we'll explain your legal options and potential compensation for expenses related to Depo-Provera.